Cannabis Investment Club

[JBGoode]

Dilution is not the case with $AAWH. A/S has remained steady, and the independent directors all just made more share purchases. Uplisted to OTCQX within the past year or so & I believe they're hoping to uplist further. IMO the pace of growth what has inhibited revenues thus far, and that growth is in some pretty significant markets.

For example, Ascend is one of only 7 multi-state operators given approval to sell in New Jersey thus far. That's a massive market (predicted to hit $2 Bil in the next few years in NJ) in an industry where buyers generally continue buying from their first good purchase experience location.